Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study.

Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study. Cancer Invest. 2007 Sep; 25(6):445-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.